BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

927 related articles for article (PubMed ID: 26846272)

  • 1. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
    Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats.
    Chen K; Li G; Geng F; Zhang Z; Li J; Yang M; Dong L; Gao F
    Apoptosis; 2014 Jun; 19(6):946-57. PubMed ID: 24664781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
    Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
    Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
    Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
    Al-Damry NT; Attia HA; Al-Rasheed NM; Al-Rasheed NM; Mohamad RA; Al-Amin MA; Dizmiri N; Atteya M
    Biomed Pharmacother; 2018 Nov; 107():347-358. PubMed ID: 30099338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of rats with increased bioavailable berberine attenuates cerebral ischemia-reperfusion injury via down regulation of adenosine-5'monophosphate kinase activity.
    Chen W; Wei S; Yu Y; Xue H; Yao F; Zhang M; Xiao J; Hatch GM; Chen L
    Eur J Pharmacol; 2016 May; 779():80-90. PubMed ID: 26957053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine attenuates ischemia-reperfusion injury via regulation of adenosine-5'-monophosphate kinase activity in both non-ischemic and ischemic areas of the rat heart.
    Chang W; Zhang M; Li J; Meng Z; Xiao D; Wei S; Chen L; Wang C; Hatch GM
    Cardiovasc Drugs Ther; 2012 Dec; 26(6):467-78. PubMed ID: 23179953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.
    Zhao GL; Yu LM; Gao WL; Duan WX; Jiang B; Liu XD; Zhang B; Liu ZH; Zhai ME; Jin ZX; Yu SQ; Wang Y
    Acta Pharmacol Sin; 2016 Mar; 37(3):354-67. PubMed ID: 26806299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6.
    Yu LM; Dong X; Xue XD; Xu S; Zhang X; Xu YL; Wang ZS; Wang Y; Gao H; Liang YX; Yang Y; Wang HS
    J Pineal Res; 2021 Jan; 70(1):e12698. PubMed ID: 33016468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and GSK3β-inhibition abrogates the infarct sparing-effect of ischemic postconditioning in ex vivo rat hearts.
    Helgeland E; Wergeland A; Sandøy RM; Askeland M; Aspevik A; Breivik L; Jonassen AK
    Scand Cardiovasc J; 2017 Jun; 51(3):159-166. PubMed ID: 28276718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.
    Morrison A; Yan X; Tong C; Li J
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury.
    Ji L; Zhang X; Liu W; Huang Q; Yang W; Fu F; Ma H; Su H; Wang H; Wang J; Zhang H; Gao F
    PLoS One; 2013; 8(7):e69910. PubMed ID: 23922853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts.
    Deng L; Chen H; Wei N; Zhang Z; Wang G
    Microvasc Res; 2019 May; 123():1-6. PubMed ID: 30179598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
    Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
    Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats.
    Qiao S; Mao X; Wang Y; Lei S; Liu Y; Wang T; Wong GT; Cheung CW; Xia Z; Irwin MG
    Crit Care Med; 2016 Mar; 44(3):e131-45. PubMed ID: 26468894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of butin against ischemia/reperfusion-induced myocardial injury in diabetic mice: involvement of the AMPK/GSK-3β/Nrf2 signaling pathway.
    Duan J; Guan Y; Mu F; Guo C; Zhang E; Yin Y; Wei G; Zhu Y; Cui J; Cao J; Weng Y; Wang Y; Xi M; Wen A
    Sci Rep; 2017 Jan; 7():41491. PubMed ID: 28128361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.